Cargando…

Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a cardiac muscle disorder characterized by generally asymmetric abnormal hypertrophy of the left ventricle without abnormal loading conditions (such as hypertension or valvular heart disease) accounting for the left ventricular wall thickness or mass. The inciden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santoro, Francesco, Mango, Federica, Mallardi, Adriana, D’Alessandro, Damiano, Casavecchia, Grazia, Gravina, Matteo, Correale, Michele, Brunetti, Natale Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218860/ https://www.ncbi.nlm.nih.gov/pubmed/37240503 http://dx.doi.org/10.3390/jcm12103397

Ejemplares similares

Arrhythmic myocarditis in an adolescent male: A unique presentation of multi-organ inflammatory syndrome (MIS-C)
por: Casavecchia, Grazia, et al.
Publicado: (2022)

Don’t stop at first glance: pulmonary artery angiosarcoma mimicking chronic thromboembolic pulmonary hypertension
por: Correale, Michele, et al.
Publicado: (2018)

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

Parachute mitral valve assessed by cardiac magnetic resonance
por: Casavecchia, Grazia, et al.
Publicado: (2019)

Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
por: Gasperetti, Alessio, et al.
Publicado: (2023)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy
por: Passini, Elisa, et al.
Publicado: (2016)

Dual Coronary-Pulmonary Fistula Firstly Found at Routine Doppler Echocardiogram
por: Casavecchia, Grazia, et al.
Publicado: (2019)

Mitral annular calcification: Can CMR be useful in identifying caseous necrosis?
por: Gravina, Matteo, et al.
Publicado: (2019)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

Tp-e interval and Tp-e/QTc ratio: new choices for risk stratification of arrhythmic events in patients with hypertrophic cardiomyopathy
por: Castro-Torres, Yaniel
Publicado: (2017)

Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach
por: Arsenos, Petros, et al.
Publicado: (2022)

Anomalous Right Coronary Artery Origin from Left Main Stem: Role of Cardio-Computed Tomography in the Diagnosis and Therapeutic Approach
por: Gravina, Matteo, et al.
Publicado: (2019)

Left Atrial Dysfunction as Marker of Arrhythmic Events in Patients with Hypertrophic Cardiomyopathy
por: Candan, Özkan, et al.
Publicado: (2022)

Tricuspid Papillary Fibroelastoma at Multimodal Imaging
por: Casavecchia, Grazia, et al.
Publicado: (2018)

A Case of Pseudo-Hypertrophic Cardiomyopathy: A Congenital Heart Disease
por: Ieva, Riccardo, et al.
Publicado: (2008)

Risk stratification in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2018)

Recent Non-Invasive Parameters to Identify Subjects at High Risk of Sudden Cardiac Death
por: Corbo, Maria Delia, et al.
Publicado: (2022)

Incidental Extracardiac Findings and Their Characterization on Cardiac MRI
por: Gravina, Matteo, et al.
Publicado: (2017)

The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy
por: Aguiar Rosa, Sílvia, et al.
Publicado: (2021)

Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
por: Du, Darson, et al.
Publicado: (2022)

Neutrophil/lymphocyte ratio predicts in‐hospital complications in Takotsubo syndrome. Results from a prospective multi‐center registry
por: Santoro, Francesco, et al.
Publicado: (2020)

Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy
por: van der Voorn, Stephanie M, et al.
Publicado: (2020)

Electrocardiographic findings and mortality in covid-19 patients hospitalized in different clinical settings
por: Mele, Marco, et al.
Publicado: (2022)

Predictors of right ventricular function improvement with sacubitril/valsartan in a real‐life population of patients with chronic heart failure
por: Correale, Michele, et al.
Publicado: (2021)

Chronic thromboembolic pulmonary hypertension mimicking coronary artery disease
por: Correale, Michele, et al.
Publicado: (2020)

Cardiac Tumors
por: Casavecchia, Grazia, et al.
Publicado: (2020)

Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry
por: Correale, Michele, et al.
Publicado: (2020)

Risk Stratification in Hypertrophic Cardiomyopathy. Insights from Genetic Analysis and Cardiopulmonary Exercise Testing
por: Magrì, Damiano, et al.
Publicado: (2020)

The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2020)

Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
por: Correale, Michele, et al.
Publicado: (2023)

Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers
por: Lyon, Aurore, et al.
Publicado: (2018)

Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
por: Jordà, Paloma, et al.
Publicado: (2018)

Coronary thrombosis due to heparin‐induced thrombocytopenia after percutaneous coronary intervention: Easy to miss, uneasy to prevent
por: Mele, Marco, et al.
Publicado: (2020)

The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic
por: Correale, Michele, et al.
Publicado: (2021)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis
por: Brunetti, Natale Daniele, et al.
Publicado: (2018)

Novel conduction-repolarization indices for the stratification of arrhythmic risk
por: Tse, Gary
Publicado: (2016)

Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure
por: Correale, Michele, et al.
Publicado: (2021)

Orthostatic Blood Pressure Test for Risk Stratification in Patients with Hypertrophic Cardiomyopathy
por: Münch, Julia, et al.
Publicado: (2015)

Compound Mutation in Cardiac Sarcomere Proteins Is Associated with Increased Risk for Major Arrhythmic Events in Pediatric Onset Hypertrophic Cardiomyopathy
por: Pollmann, Kathrin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qbgv8fu0plr91hrsk5lvb1ahtl